Core Viewpoint - Rosen Law Firm is reminding investors who purchased Quantum Corporation securities between November 15, 2024, and August 18, 2025, about the upcoming lead plaintiff deadline for a securities class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Quantum Corporation securities during the specified class period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must file with the court by November 3, 2025 [3]. - The lawsuit alleges that Quantum Corporation made false or misleading statements regarding its revenue recognition and will need to restate financial statements for the fiscal third quarter ended December 31, 2024 [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in recovering significant settlements for investors [4]. - The firm has been recognized for its performance in securities class action settlements, including being ranked No. 1 by ISS Securities Class Action Services in 2017 and securing over $438 million for investors in 2019 alone [4].

Core Viewpoint - A federal securities fraud class action lawsuit has been filed against LifeMD, alleging misleading representations regarding its financial health and growth prospects, following a significant stock price decline after its earnings report in August 2025 [1][4]. Summary by Sections Lawsuit Details - The lawsuit, titled Johnston v. LifeMD, Inc., focuses on the period from May 7, 2025, to August 5, 2025, claiming that LifeMD made false statements, particularly during its first-quarter results announcement on May 6, 2025, when it raised its full-year revenue and adjusted EBITDA guidance [2][4]. - The complaint asserts that LifeMD's optimistic outlook regarding its competitive position in virtual obesity care and performance from its RexMD brand was misleading, as it did not disclose significant operational challenges [2][3]. Financial Performance and Stock Impact - LifeMD's issues included rising customer acquisition costs in its RexMD segment and a higher-than-expected refund rate in its weight management business, which were not disclosed to investors [3]. - The situation escalated on August 5, 2025, when LifeMD reported second-quarter results that missed revenue and earnings per share estimates, leading to a reduction in its full-year guidance. The stock price subsequently dropped by over 44% the following day [4]. Investor Actions - The lawsuit provides an opportunity for investors who experienced substantial losses during the specified period to seek recovery [5]. - Hagens Berman, the law firm investigating these claims, is looking into whether LifeMD was aware of but failed to disclose key operational issues [6].

Company Overview - Netflix provides entertainment services with over 300 million paid memberships in over 190 countries [2] Investigation Details - Robbins Geller is investigating potential violations of U.S. federal securities laws involving Netflix and whether the company and its top executives made materially false and/or misleading statements or omitted material information regarding its business and operations [1][2] Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm representing investors in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [3]

Core Viewpoint - Baxter International, Inc. is facing a class action lawsuit due to allegations of misleading statements and undisclosed systemic defects in its Novum IQ Large Volume Pump, which have resulted in serious patient risks and a significant drop in stock price [3][4]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled Electrical Workers Pension Fund, Local 103, I.B.E.W. v. Baxter International, Inc., and covers purchasers of Baxter common stock from February 23, 2022, to July 30, 2025 [1]. - Investors have until December 15, 2025, to seek appointment as lead plaintiff in the lawsuit [1]. - The lawsuit alleges that Baxter's Novum IQ Large Volume Pump had systemic defects leading to malfunctions that posed risks of serious injury or death to patients [3]. Group 2: Allegations Against Baxter - Baxter was reportedly aware of multiple device malfunctions, injuries, and deaths related to the Novum LVP but failed to adequately address these issues [3]. - On July 31, 2025, Baxter announced a voluntary and temporary pause in shipments and installations of the Novum LVP, which contributed to a more than 22% drop in the company's stock price [4]. Group 3: Legal Process and Representation - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Baxter common stock during the class period to seek lead plaintiff status [5]. - The lead plaintiff will represent the interests of all class members and can select a law firm of their choice for litigation [5]. Group 4: About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading firm in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [6]. - The firm has been ranked 1 in securing monetary relief for investors in securities class action cases for four out of the last five years [6].

Core Viewpoint - A class action lawsuit has been filed against LifeMD, Inc. for allegedly overstating its competitive position and providing unrealistic financial guidance for 2025, leading to significant investor losses when the truth was revealed [3]. Group 1: Lawsuit Details - The lawsuit is initiated by Berger Montague on behalf of investors who acquired LifeMD shares between May 7, 2025, and August 5, 2025 [1][2]. - Investors have until October 27, 2025, to seek appointment as lead plaintiff representatives [2]. - The complaint alleges that LifeMD did not disclose rising customer acquisition costs associated with its RexMD platform and its promotion of obesity medications like Wegovy and Zepbound [3]. Group 2: Company Background - LifeMD, headquartered in New York, provides virtual medical services and prescription delivery [2]. - The firm has been accused of making materially false and misleading statements throughout the class period, lacking a reasonable basis for its claims [3].

Core Viewpoint - The Law Offices of Howard G. Smith has announced a securities fraud class action lawsuit against aTyr Pharma Inc., inviting investors who suffered substantial losses to participate in the lawsuit [1][3]. Summary by Relevant Sections Lawsuit Details - The lawsuit alleges that between January 16, 2025, and September 12, 2025, aTyr Pharma Inc. failed to disclose critical information regarding its EFZO-FIT study, misleading investors about the drug Efzofitimod's potential to meet its primary endpoint [3]. - Specific allegations include the creation of adverse facts about the study design, misleading narratives about steroid removal for patients, and the failure of the Phase 3 EFZO-FIT study to meet its primary endpoint regarding the mean daily OCS dose at week 48 [3]. Participation Information - Investors interested in participating in the class action lawsuit must contact the Law Offices of Howard G. Smith before December 8, 2025, which is the lead plaintiff deadline [2][4]. - The law firm provides various contact methods, including email and telephone, for investors to discuss their legal rights [2][4].

Core Viewpoint - Investors in WPP plc have the opportunity to lead a securities fraud class action lawsuit due to alleged misleading statements regarding the company's ability to handle macroeconomic challenges and market competition [1][2]. Summary by Sections Lawsuit Details - The lawsuit claims that from February 27, 2025, to July 8, 2025, WPP's media arm was not adequately prepared for ongoing macroeconomic challenges and was losing significant market share to competitors [2]. - It is alleged that the positive statements made by WPP's management about the company's business and prospects were materially misleading and lacked a reasonable basis during this period [2]. Participation Information - Investors who suffered losses related to WPP plc are encouraged to participate in the lawsuit before the lead plaintiff deadline of December 8, 2025 [2]. - Interested parties can contact the Law Offices of Frank R. Cruz for more information or to participate in the class action [3][4].

Core Insights - Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Jefferies Financial Group Inc., focusing on whether Jefferies and certain executives made false or misleading statements or failed to disclose material information to investors [1] Company Overview - Jefferies Financial Group Inc. is a global full-service investment banking and capital markets firm, managing and providing services to a diverse group of alternative asset management platforms under the Leucadia Asset Management umbrella [2] Recent Developments - On September 29, 2025, The Wall Street Journal reported that First Brands filed for bankruptcy amid accounting questions, with lenders and independent board directors probing potential misrepresentations in financial reporting [3] - Jefferies disclosed that funds run by its asset-management unit, Point Bonita Capital, are owed approximately $715 million from companies that purchased parts from First Brands [3] - The U.S. Department of Justice has launched an inquiry into the collapse of First Brands Group, investigating the company's dealings with creditors [3] - Reports indicated that First Brands' former CEO was working on refinancing nearly $6 billion of corporate loans with Jefferies, but did not disclose billions of dollars of off-balance-sheet debt to prospective lenders [3]

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving Mr. Cooper Group Inc. and its officers or directors [1] Group 1: Investigation Details - Pomerantz LLP is representing investors of Mr. Cooper Group Inc. and is looking into claims of securities fraud [1] - Investors are encouraged to contact Pomerantz LLP for more information regarding the investigation [1] Group 2: Merger Implications - The merger is projected to generate $100 million in additional pre-tax revenue and $500 million in run-rate pre-tax cost savings [3] - The merger is expected to be immediately accretive to Rocket's earnings per share and mid-teens accretive on a percentage basis to estimated 2026 earnings per share [3] - Following the merger's closing on October 1, 2025, Rocket's share price has significantly declined [4] Group 3: Regulatory Issues - The FTC has sued Zillow and Rocket subsidiary Redfin over an unlawful agreement that restricts competition in the advertising market for rental housing [3] - The lawsuit alleges that Redfin agreed to eliminate competition in exchange for a $100 million payment from Zillow [3]

Core Viewpoint - Halper Sadeh LLC is investigating potential breaches of fiduciary duties by certain officers and directors of GeneDx Holdings Corp, urging shareholders to contact the firm to discuss their rights and possible legal actions [1][2]. Group 1: Shareholder Rights and Legal Options - Shareholders who acquired GeneDx stock on or before January 18, 2022, may seek corporate governance reforms, return of funds, court-approved financial incentives, or other benefits [2]. - The firm operates on a contingent fee basis, meaning shareholders would not incur out-of-pocket legal fees or expenses [2]. Group 2: Importance of Shareholder Participation - Shareholder involvement is crucial for improving company policies, practices, and oversight, which can lead to enhanced transparency, accountability, and ultimately, increased shareholder value [3]. Group 3: Firm's Background and Experience - Halper Sadeh LLC represents global investors affected by securities fraud and corporate misconduct, having successfully implemented corporate reforms and recovered millions for defrauded investors [4].